申请人:Burzynski Stanislaw R.
公开号:US10624869B2
公开(公告)日:2020-04-21
Methods for the treatment of cancer, including glioblastoma multiforme (GBM) and recurrent glioblastoma multiforme (RGBM). The method includes administering to a patient a plurality of extraneous antineoplastons and a plurality of targeted agents. The plurality of extraneous antineoplastons may include two or more antineoplastons selected from phenylacetylglutaminate sodium (PG), phenylacetylisoglutaminate sodium (iso-PG), and phenylacetate (PN). The plurality of targeted agents may include two or more agents selected from bevacizumab, pazopanib, sorafenib, dasatinib, and everolimus.
治疗癌症的方法,包括多形性胶质母细胞瘤(GBM)和复发性多形性胶质母细胞瘤(RGBM)。该方法包括向患者施用多种外来抗肿瘤药物和多种靶向药物。多种外来抗肿瘤药物可包括选自苯乙酰谷氨酸钠(PG)、苯乙酰异谷氨酸钠(iso-PG)和苯乙酸盐(PN)的两种或多种抗肿瘤药物。多种靶向药物可包括两种或两种以上选自贝伐珠单抗、帕佐帕尼、索拉非尼、达沙替尼和依维莫司的药物。